Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Long-Term Administration of Sopungsungi-won (SP) Prevents Diabetic Nephropathy in Zucker Diabetic Fatty Rats

  • Kim, Youn-Young (Laboratory of Pharmacology, School of Pharmacy, Kyung Hee University) ;
  • Kang, Kwi-Man (Laboratory of Pharmacology, School of Pharmacy, Kyung Hee University) ;
  • Chung, Sung-Hyun (Laboratory of Pharmacology, School of Pharmacy, Kyung Hee University)
  • Published : 2002.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

We investigated the long term effects of Sopungsungi-won (SP), a Korean traditional formula used for senile constipation and diabetes mellitus, on the development of diabetic nephropathy (DN) in Zucker diabetic fatty (ZDF) rats. ZDF rats were fed regular laboratory chow mixed with SP or rosiglitazone (RSG) for an 8-week period. Kidney hypertrophy was developed with increasing plasma glucose level, and glomerular hypertrophy was improved by 22% and 45% in SP- and RSG-treated rats, respectively. Urinary glucose and albumin excretions were also significantly lower in SP-treated rats than in ZDF control rats. Activation of the mitogen-activated protein kinase (MAPK)-transforming growth factor ${\beta}1$ (TGF ${\beta}1$)-fibronectin pathway in kidney, responsible for glomerular dysfunction, was markedly blunted by SP treatment in a dose dependent manner. Our findings, for the first time, provide strong evidence that long-term administration of SP formula prevents the development and progression of DN in ZDF rats. Human trials are needed to confirm these experimental results.

Keywords

References

  1. Awazu, M., Ishikura, K., Hida M. and Hoshiya, M., Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J. Am. Soc. Nephr., 10, 738-745 (1999)
  2. Borkemeyer, D., Sorokin, A. and Dunn, M. J., Multiple intracellular MAP kinase signaling cascades. Kidney lnternational, 49, 1187-1198 (1996) https://doi.org/10.1038/ki.1996.172
  3. Brownlee, M., Cerami, A. and Vlassara, H., Advanced glycosylation end products in tissue and biochemical basis of diabetic complications. New England Journal of Medicine, 318, 1315-1321 (1987) https://doi.org/10.1056/NEJM198805193182007
  4. Cooper, M. E., Interaction of metabolic and hemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia, 44, 1957-1972 (2001) https://doi.org/10.1007/s001250100000
  5. Craven, P. A. and DeRubertis, F. R., Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J. Clin. lnvest., 83, 1667-1675 (1989) https://doi.org/10.1172/JCI114066
  6. Greene, D., Lattimer, S. A. and Sima, A. A. F, Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. New England Journal of Medicine, 316, 599-606 (1987) https://doi.org/10.1056/NEJM198703053161007
  7. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M. and Kikkawa R., Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes, 46, 847-853 (1997) https://doi.org/10.2337/diabetes.46.5.847
  8. Hoffman B., Sharma K., Zhu Y. and Ziyadeh F. N., Transcriptional activation of transforming growth factor-$\beta$1 in mesangial cell culture by high glucose concentration. Kidney International, 54, 1107-1116 (1998) https://doi.org/10.1046/j.1523-1755.1998.00119.x
  9. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z. Y., Yamauchi T., Kuboki K., Meier M., Rhodes C. J. and King G. L, Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest., 103(2), 185-95 (1999) https://doi.org/10.1172/JCI3326
  10. Isono M., Mogyorosi A., Han D. C., Hoffman B. B. and Ziyadeh F. N., Stimulation of TGF-$\beta$ type II receptor by high glucose in mousie mesangial cells and in diabetic kidney. Am. J. Physiol., 278, F830 -F838 (2000)
  11. Kang M. J., Wu X., Ly H., Thai K. and Scholey W., Effect of glucose on stress-activated protein kinase activity in mesangial cells and diabetic glomeruli. Kidney International, 55, 2203-2214 (1999) https://doi.org/10.1046/j.1523-1755.1999.00488.x
  12. Koya, D., and King, G. L., Protein kinase C activation and the development of diabetic complication. Diabetes, 47, 859-866 (1998) https://doi.org/10.2337/diabetes.47.6.859
  13. Lowry O. H., Rosebrough W. I., Farr A. L. and Randal R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951)
  14. Segar R. and Krebs E. G., The MAPK signaling cascade. FASEB Journal, 9, 726-735 (1995) https://doi.org/10.1096/fasebj.9.9.7601337
  15. The Diabetes Control Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986 (1993) https://doi.org/10.1056/NEJM199309303291401